Interpace Biosciences, Inc. (IDXG) Shareholders’ equity 2016–2025
Interpace Biosciences, Inc. (IDXG) shareholders’ equity at each fiscal year-end, per SEC filings.
$22.4MFY2025 · since FY2016: -$10.1M → $22.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.4M | +1108.7% |
| FY2024 | -$2.2M | +96.0% |
| FY2023 | -$55.5M | +4.4% |
| FY2022 | -$58.1M | -36.9% |
| FY2021 | -$42.4M | -45.9% |
| FY2020 | -$29.1M | -549.3% |
| FY2019 | -$4.5M | -129.0% |
| FY2018 | $15.4M | -32.5% |
| FY2017 | $22.9M | +326.4% |
| FY2016 | -$10.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice